Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative

Read the paper here: Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative

Piccini J, et al. Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative. Am Heart J. 2009; 158(3): 317-326